230 related articles for article (PubMed ID: 24636377)
1. Antiparkinson drug adherence and its association with health care utilization and economic outcomes in a Medicare Part D population.
Wei YJ; Palumbo FB; Simoni-Wastila L; Shulman LM; Stuart B; Beardsley R; Brown CH
Value Health; 2014 Mar; 17(2):196-204. PubMed ID: 24636377
[TBL] [Abstract][Full Text] [Related]
2. Antiparkinson drug use and adherence in medicare part D beneficiaries with Parkinson's disease.
Wei YJ; Palumbo FB; Simoni-Wastila L; Shulman LM; Stuart B; Beardsley R; Brown C
Clin Ther; 2013 Oct; 35(10):1513-1525.e1. PubMed ID: 24139423
[TBL] [Abstract][Full Text] [Related]
3. Relationships between antiparkinson medication nonadherence, regimen modifications, and healthcare utilization and expenditures.
Wei YJ; Palumbo FB; Simoni-Wastila L; Shulman LM; Stuart B; Beardsley R; Brown C
Parkinsonism Relat Disord; 2015 Jan; 21(1):36-41. PubMed ID: 25465748
[TBL] [Abstract][Full Text] [Related]
4. Association of chronic obstructive pulmonary disease maintenance medication adherence with all-cause hospitalization and spending in a Medicare population.
Simoni-Wastila L; Wei YJ; Qian J; Zuckerman IH; Stuart B; Shaffer T; Dalal AA; Bryant-Comstock L
Am J Geriatr Pharmacother; 2012 Jun; 10(3):201-10. PubMed ID: 22521808
[TBL] [Abstract][Full Text] [Related]
5. Medication adherence and associated outcomes in medicare health maintenance organization-enrolled older adults with Parkinson's disease.
Kulkarni AS; Balkrishnan R; Anderson RT; Edin HM; Kirsch J; Stacy MA
Mov Disord; 2008 Feb; 23(3):359-65. PubMed ID: 18074366
[TBL] [Abstract][Full Text] [Related]
6. Economic burden associated with Parkinson's disease on elderly Medicare beneficiaries.
Noyes K; Liu H; Li Y; Holloway R; Dick AW
Mov Disord; 2006 Mar; 21(3):362-72. PubMed ID: 16211621
[TBL] [Abstract][Full Text] [Related]
7. Prevalence and cost of medication nonadherence in Parkinson's disease: evidence from administrative claims data.
Davis KL; Edin HM; Allen JK
Mov Disord; 2010 Mar; 25(4):474-80. PubMed ID: 20131374
[TBL] [Abstract][Full Text] [Related]
8. Impact of second-generation antipsychotics on the use of antiparkinson agents in nursing homes and assisted-living facilities.
Touré JT; Brandt NJ; Limcangco MR; Briesacher BA
Am J Geriatr Pharmacother; 2006 Mar; 4(1):25-35. PubMed ID: 16730618
[TBL] [Abstract][Full Text] [Related]
9. Impact of Medicare Part D for Medicare-age adults with arthritis: prescription use, prescription expenditures, and medical spending from 2005 to 2008.
Cheng LI; Rascati KL
Arthritis Care Res (Hoboken); 2012 Sep; 64(9):1423-9. PubMed ID: 22508663
[TBL] [Abstract][Full Text] [Related]
10. Increasing Medicare part D enrollment in medication therapy management could improve health and lower costs.
Stuart B; Loh FE; Roberto P; Miller LM
Health Aff (Millwood); 2013 Jul; 32(7):1212-20. PubMed ID: 23836736
[TBL] [Abstract][Full Text] [Related]
11. Implementation of Medicare Part D and nondrug medical spending for elderly adults with limited prior drug coverage.
McWilliams JM; Zaslavsky AM; Huskamp HA
JAMA; 2011 Jul; 306(4):402-9. PubMed ID: 21791689
[TBL] [Abstract][Full Text] [Related]
12. Medicaid beneficiaries with congestive heart failure: association of medication adherence with healthcare use and costs.
Esposito D; Bagchi AD; Verdier JM; Bencio DS; Kim MS
Am J Manag Care; 2009 Jul; 15(7):437-45. PubMed ID: 19589011
[TBL] [Abstract][Full Text] [Related]
13. Differences in health services utilization and costs between antihypertensive medication users versus nonusers in adults with diabetes and concomitant hypertension from Medical Expenditure Panel Survey pooled years 2006 to 2009.
Davis-Ajami ML; Wu J; Fink JC
Value Health; 2014; 17(1):51-61. PubMed ID: 24438717
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of healthcare utilization and health status of patients with Parkinson's disease treated with deep brain stimulation of the subthalamic nucleus.
Spottke EA; Volkmann J; Lorenz D; Krack P; Smala AM; Sturm V; Gerstner A; Berger K; Hellwig D; Deuschl G; Freund HJ; Oertel WH; Dodel RC
J Neurol; 2002 Jun; 249(6):759-66. PubMed ID: 12111311
[TBL] [Abstract][Full Text] [Related]
15. Burden of chronic obstructive pulmonary disease in Medicare beneficiaries residing in long-term care facilities.
Simoni-Wastila L; Blanchette CM; Qian J; Yang HW; Zhao L; Zuckerman IH; Pak GH; Silver H; Dalal AA
Am J Geriatr Pharmacother; 2009 Oct; 7(5):262-70. PubMed ID: 19948302
[TBL] [Abstract][Full Text] [Related]
16. Health care utilization by old-old long-term care facility residents: how do Medicare fee-for-service and capitation rates compare?
Phillips VL; Paul W; Becker ER; Osterweil D; Ouslander JG
J Am Geriatr Soc; 2000 Oct; 48(10):1330-6. PubMed ID: 11037023
[TBL] [Abstract][Full Text] [Related]
17. How Much Does Medication Nonadherence Cost the Medicare Fee-for-Service Program?
Lloyd JT; Maresh S; Powers CA; Shrank WH; Alley DE
Med Care; 2019 Mar; 57(3):218-224. PubMed ID: 30676355
[TBL] [Abstract][Full Text] [Related]
18. Treatment patterns and associated costs with Parkinson's disease levodopa induced dyskinesia.
Suh DC; Pahwa R; Mallya U
J Neurol Sci; 2012 Aug; 319(1-2):24-31. PubMed ID: 22664154
[TBL] [Abstract][Full Text] [Related]
19. Health care utilization among Medicare-Medicaid dual eligibles: a count data analysis.
Moon S; Shin J
BMC Public Health; 2006 Apr; 6():88. PubMed ID: 16595021
[TBL] [Abstract][Full Text] [Related]
20. Hypertension, cholesterol and diabetes medication adherence, health care utilization and expenditure in a Medicare Supplemental sample.
Campbell PJ; Axon DR; Taylor AM; Smith K; Pickering M; Black H; Warholak T; Chinthammit C
Medicine (Baltimore); 2021 Sep; 100(35):e27143. PubMed ID: 34477169
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
